2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议

2018-07-30 中国眼科相关专家组(统称) Taiwan J Ophthalmol. 2018 Jul-Sep;8(3):117-120.

非感染性葡萄膜炎是一种具有自身免疫或基于自身炎症的影响视力的疾病,如果眼内炎症影响患者视力,或当其与全身风湿性疾病相关不能局部控制时则需进场全身性治疗。本文主要针对抗肿瘤坏死因子α的临床应用提供指导建议。

中文标题:

2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议

英文标题:

Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan.

发布日期:

2018-07-30

简要介绍:

非感染性葡萄膜炎是一种具有自身免疫或基于自身炎症的影响视力的疾病,如果眼内炎症影响患者视力,或当其与全身风湿性疾病相关不能局部控制时则需进场全身性治疗。本文主要针对抗肿瘤坏死因子α的临床应用提供指导建议。 

拓展指南:葡萄膜炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议)] GetToolGuiderByIdResponse(projectId=1, id=d77ee1c001650a3e, title=2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议, enTitle=Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan., guiderFrom=Taiwan J Ophthalmol. 2018 Jul-Sep;8(3):117-120., authorId=null, author=, summary=非感染性葡萄膜炎是一种具有自身免疫或基于自身炎症的影响视力的疾病,如果眼内炎症影响患者视力,或当其与全身风湿性疾病相关不能局部控制时则需进场全身性治疗。本文主要针对抗肿瘤坏死因子α的临床应用提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=1043, associationName=中国眼科相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jul 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>非感染性葡萄膜炎是一种具有自身免疫或基于自身炎症的影响视力的疾病,如果眼内炎症影响患者视力,或当其与全身风湿性疾病相关不能局部控制时则需进场全身性治疗。本文主要针对抗肿瘤坏死因子α的临床应用提供指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>葡萄膜炎</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2db811c0015e5626" title="2018 欧洲共识建议:少年特发性关节炎相关性葡萄膜炎的管理" target=_blank>2018 欧洲共识建议:少年特发性关节炎相关性葡萄膜炎的管理</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%91%A1%E8%90%84%E8%86%9C%E7%82%8E" target=_blank>有关葡萄膜炎更多指南</a></ul>, tagList=[TagDto(tagId=76784, tagName=抗肿瘤坏死因子α), TagDto(tagId=34925, tagName=非感染性葡萄膜炎)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6916, appHits=97, showAppHits=9, pcHits=5882, showPcHits=1551, likes=147, shares=1, comments=2, approvalStatus=1, publishedTime=Fri Oct 12 23:31:19 CST 2018, publishedTimeString=2018-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Oct 12 23:31:19 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:45:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议)])
2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=349120, encodeId=bee6349120aa, content=嗯嗯,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Oct 13 07:23:25 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349109, encodeId=858734910994, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Oct 13 07:21:08 CST 2018, time=2018-10-13, status=1, ipAttribution=)]
    2018-10-13 liumin1987

    嗯嗯,学习了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=349120, encodeId=bee6349120aa, content=嗯嗯,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Oct 13 07:23:25 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349109, encodeId=858734910994, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Oct 13 07:21:08 CST 2018, time=2018-10-13, status=1, ipAttribution=)]
    2018-10-13 明月清辉

    谢谢分享,学习了

    0